Try our beta test site
Trial record 1 of 1 for:    NCT01493505
Previous Study | Return to List | Next Study

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

This study has been terminated.
(Amgen Administrative Decision - termination of LTFU)
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT01493505
First received: September 29, 2011
Last updated: February 22, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: November 14, 2016